Trial Profile
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Pilot Study.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Carcinoma; Cervical cancer; Endometrial cancer; Ovarian cancer
- Focus Diagnostic use
- 27 Feb 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 27 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 19 Mar 2019 Status changed from not yet recruiting to recruiting.